Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.
Follow-Up Questions
Who is the CEO of Takeda Pharmaceutical Co Ltd?
Mr. Christophe Weber is the President of Takeda Pharmaceutical Co Ltd, joining the firm since 2014.
What is the price performance of TAK stock?
The current price of TAK is $13.53, it has increased 0.82% in the last trading day.
What are the primary business themes or industries for Takeda Pharmaceutical Co Ltd?
Takeda Pharmaceutical Co Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Takeda Pharmaceutical Co Ltd market cap?
Takeda Pharmaceutical Co Ltd's current market cap is $42.7B
Is Takeda Pharmaceutical Co Ltd a buy, sell, or hold?
According to wall street analysts, 17 analysts have made analyst ratings for Takeda Pharmaceutical Co Ltd, including 3 strong buy, 8 buy, 9 hold, 0 sell, and 3 strong sell
